Breaking the fibrotic code: Nanotechnology-driven advances in renal fibrosis therapy
- 24 September 2025
- journal article
- review article
- Published by Elsevier in Biomaterials
- Vol. 327, 123738
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82204746)
- National Natural Science Foundation of China (82003982)
- Natural Science Foundation of Gansu Province (25JRRA810)
This publication has 286 references indexed in Scilit:
- Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery NanocarriersAdvanced Materials, 2024
- Zinc citrate‐coated whey protein nanoparticles alleviate kidney damage and the disturbances in inflammatory gene expression in ratsJournal of Biochemical and Molecular Toxicology, 2023
- Promising renoprotective effect of gold nanoparticles and dapagliflozin in diabetic nephropathy via targeting miR‐192 and miR‐21Journal of Biochemical and Molecular Toxicology, 2023
- Metabolic reprogramming heterogeneity in chronic kidney diseaseFEBS Open Bio, 2023
- Organoids: A new approach in toxicity testing of nanotherapeuticsJournal of Applied Toxicology, 2021
- The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticlesBioengineering & Translational Medicine, 2020
- Small‐Sized Cationic miRi‐PCNPs Selectively Target the Kidneys for High‐Efficiency Antifibrosis TreatmentAdvanced Healthcare Materials, 2018
- Interactions of Renal‐Clearable Gold Nanoparticles with Tumor Microenvironments: Vasculature and Acidity EffectsAngewandte Chemie International Edition, 2017
- Tailoring Renal Clearance and Tumor Targeting of Ultrasmall Metal Nanoparticles with Particle DensityAngewandte Chemie International Edition, 2016
- High‐contrast Noninvasive Imaging of Kidney Clearance Kinetics Enabled by Renal Clearable NanofluorophoresAngewandte Chemie International Edition, 2015